Build your portfolio of top-class funds today.
Start systematic investing now!
ITI Pharma & Healthcare Fund - Growth - Direct Plan has delivered CAGR and average rolling returns as follows :
1 Year | 3 Year | 5 Year | 9 Year | |
CAGR(%) | 59.08 | N/A | N/A | N/A |
Average Rolling Returns(%) | 26.50 | N/A | N/A | N/A |
The Current NAV of ITI Pharma & Healthcare Fund - Growth - Direct Plan is ₹17.52.
It is better to invest in a fund with a longer track record as ITI Pharma & Healthcare Fund - Growth - Direct Plan cannot be assessed for consistency of out-performance. Funds returns are more likely to be different than its benchmark NIFTY 500 returns, as Funds portfolio is significantly different.
ITI Pharma & Healthcare Fund - Growth - Direct Plan fund’s expense ratio is 0.47%
The process for redemption is
The AUM of ITI Pharma & Healthcare Fund - Growth - Direct Plan is currently ₹208 Crores.
The Top three stocks are Sun Pharma Inds., Lupin and Suven Pharma and account for 28% of its portfolio. Top 5 and 10 stocks of fund account for 39% and 55% of fund’s portfolio respectively.
Top three sectors of ITI Pharma & Healthcare Fund - Growth - Direct Plan fund are Healthcare, Miscellaneous and Chemicals accounting for 98% of the total portfolio.
Funds Portfolio Quality is Very Good. It has a large proportion of Green Stocks.Since this is a Equity - Sectoral Fund - Pharma & Health Care it is comparatively safer to invest in this fund. However, since it has not consistently outperformed its benchmark index on an average 3-year rolling returns basis it is not the most suitable fund for SIP.
The category of ITI Pharma & Healthcare Fund - Growth - Direct Plan Fund is Equity - Sectoral Fund - Pharma & Health Care.
Rohan Korde and Dhimant Shah manage the ITI Pharma & Healthcare Fund - Growth - Direct Plan Fund.
ITI Pharma & Healthcare Fund - Growth - Direct Plan current PE ratio is 61.90 and PB ratio is 8.07
The asset allocation of ITI Pharma & Healthcare Fund - Growth - Direct Plan is Stocks : 98.20%, Debt : 1.80% and Gold : 0%
The minimum SIP amount for ITI Pharma & Healthcare Fund - Growth - Direct Plan is ₹500.00 and minimum lumpsum is ₹5000.00
The exit load for ITI Pharma & Healthcare Fund - Growth - Direct Plan is 1% on or before 12 months, Nil after 12 months